Cerevance Lands $36,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6c0e6949-a55e-4689-8446-b600c92ea3d0 - Date
12/6/2016 - Company Name
Cerevance - Mailing Address
One Kendall Square Cambridge, MA 02139 USA - Company Description
Cerevance is a neuroscience company focused on discovering and developing novel therapeutics for neurological and psychiatric disorders. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$36,000,000 - Transaction Round
Series A - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
Takeda Ventures - Venture Investor
Lightstone Ventures
